PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.86M invested in Purple Biotech in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

75% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 20

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$127K
2
+$50K
3
+$26.2K
4
ECM
ETrade Capital Management
Virginia
+$22.4K
5
YAL
Your Advocates Ltd
Texas
+$2K

Top Sellers

1
-$400K
2
-$281K
3
-$119K
4
UBS Group
UBS Group
Switzerland
-$117K
5
JPMPWA
J.P. Morgan Private Wealth Advisors
California
-$56K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.53M
2
$127K
3
$76K
4
$50K
5
$27K
6
$11K
7
$11K
8
$10K
9
$9K
10
$4K
11
$2K
12
$2K
13
$1K
14
$1K
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–
1
2